John McDonough is Director at T2 Biosystems, Inc. (TTOO). They have made 3 open-market trades across 1 company since 2018, most recently 2021-07-01.
CIK 0001615937
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TTOO | 516,386 | $69K |
Shares reported on the most recent Form 4, priced at the 2021-07-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TTOO | SELL · 10b5-1 | 2021-07-01 | 2021-07-02 | $1.16 | $21K | -6.3% | -4.5% | -18.3% |
| TTOO | SELL · 10b5-1 | 2020-02-03 | 2020-02-05 | $0.88 | $21K | +15.8% | -40.8% | -37.3% |
| TTOO | SELL | 2020-01-23 | 2020-01-27 | $1.15 | $132K | -21.9% | -43.2% | -51.2% |
| TTOO | SELL · 10b5-1 | 2019-02-11 | 2019-02-12 | $3.36 | $27K | +14.4% | -23.9% | -27.3% |
| TTOO | SELL | 2019-01-31 | 2019-02-05 | $3.43 | $49K | +1.1% | -14.0% | -21.1% |
| TTOO | SELL | 2018-02-09 | 2018-06-08 | $4.28 | $27K | -13.5% | -19.5% | -30.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.